CRA role evolving to provide more QA and site support
New data reveals added responsibilities, demanding workload
Sites seek arsenal of new tactics in battle for research contracts
Marketing savvy, business development, technology keep sites on cutting edge
MedImmune attributes its strength in the biotechnology sector to discovery, research optimization, process development, entrepreneurial spirit and its “unwavering commitment to the development of new biologics that hold tremendous potential for patients around the globe.” The company is considered to be an industry leader in the manufacture of monoclonal antibodies and live viral vaccines.